6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Home Blood Pressure Monitoring via a Smartphone Hypertension Coaching Application or Tracking Application on Adults With Uncontrolled Hypertension : A Randomized Clinical Trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Does an artificial intelligence smartphone coaching application (app) improve blood pressure and hypertension-associated behaviors?

          Findings

          In this randomized clinical trial of 297 adults with uncontrolled hypertension, participants randomized to a smartphone coaching app did not have lower blood pressure at 6 months compared with those receiving a blood pressure tracking app. The study was not large enough to detect small but potentially important intervention effects.

          Meaning

          Benefits of combining this mobile coaching app with home monitoring were not established in this trial.

          Abstract

          This randomized clinical trial investigates the effect on blood pressure of an artificial intelligence smartphone coaching application (app) designed to promote home monitoring and behavioral changes vs a blood pressure tracking smartphone app.

          Abstract

          Importance

          Mobile applications (apps) may help improve hypertension self-management.

          Objective

          To investigate the effect of an artificial intelligence smartphone coaching app to promote home monitoring and hypertension-related behaviors on systolic blood pressure level compared with a blood pressure tracking app.

          Design, Setting, and Participants

          This was a 2-group, open, randomized clinical trial. Participants with uncontrolled hypertension were recruited in 2016 and 2017 and were followed up for 6 months. Data analysis was performed from April 2019 to December 2019.

          Interventions

          Intervention group participants received a smartphone coaching app to promote home monitoring and behavioral changes associated with hypertension self-management plus a home blood pressure monitor. Control participants received a blood pressure tracking app plus a home blood pressure monitor.

          Main Outcomes and Measures

          The primary study outcome was systolic blood pressure at 6 months. Secondary outcomes included self-reported antihypertensive medication adherence, home monitoring and self-management practices, measures of self-efficacy associated with blood pressure, weight, and self-reported health behaviors.

          Results

          There were 333 participants randomized, and 297 completed the follow-up assessment. Among the participants who completed the study, the mean (SD) age was 58.9 (12.8) years, 182 (61.3%) were women, and 103 (34.7%) were black. Baseline mean (SD) systolic blood pressure was 140.6 (12.2) mm Hg among intervention participants and 141.8 (13.4) mm Hg among control participants. After 6 months, the corresponding mean (SD) systolic blood pressures were 132.3 (15.0) mm Hg and 135.0 (13.9) mm Hg, with a between-group adjusted difference of −2.0 mm Hg (95% CI, −4.9 mm Hg to 0.8 mm Hg; P = .16). At 6 months, self-confidence in controlling blood pressure was greater in the intervention group (0.36 point on a 5-point scale; 95% CI, 0.18 point to 0.54 point; P < .001). There were no significant differences between the 2 groups in other secondary outcomes. The adjusted difference in self-reported physical activity was 26.7 minutes per week (95% CI, −5.4 minutes per week to 58.8 minutes per week; P = .10). Subgroup analysis raised the possibility that intervention effects differed by age.

          Conclusions and Relevance

          Among individuals with uncontrolled hypertension, those randomized to a smartphone coaching app plus home monitor had similar systolic blood pressure compared with those who received a blood pressure tracking app plus home monitor. Given the direction of the difference in systolic blood pressure between groups and the possibility for differences in treatment effects across subgroups, future studies are warranted.

          Trial Registration

          ClinicalTrials.gov Identifier: NCT03288142

          Related collections

          Most cited references27

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

            Research electronic data capture (REDCap) is a novel workflow methodology and software solution designed for rapid development and deployment of electronic data capture tools to support clinical and translational research. We present: (1) a brief description of the REDCap metadata-driven software toolset; (2) detail concerning the capture and use of study-related metadata from scientific research teams; (3) measures of impact for REDCap; (4) details concerning a consortium network of domestic and international institutions collaborating on the project; and (5) strengths and limitations of the REDCap system. REDCap is currently supporting 286 translational research projects in a growing collaborative network including 27 active partner institutions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

              Circulation, 139(10)
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                2 March 2020
                March 2020
                2 March 2020
                : 3
                : 3
                : e200255
                Affiliations
                [1 ]Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
                [2 ]Center for Primary Care Innovation, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
                [3 ]Omron Healthcare Co Ltd, Kyoto, Japan
                [4 ]Division of Biostatistics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
                [5 ]Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
                Author notes
                Article Information
                Accepted for Publication: December 17, 2019.
                Published: March 2, 2020. doi:10.1001/jamanetworkopen.2020.0255
                Open Access: This is an open access article distributed under the terms of the CC-BY-NC-ND License. © 2020 Persell SD et al. JAMA Network Open.
                Corresponding Author: Stephen D. Persell, MD, MPH, Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, 750 N Lake Shore Dr, 10th Floor, Chicago, IL 60611 ( spersell@ 123456nm.org ).
                Author Contributions: Dr Persell and Ms Lee had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Persell, Peprah, Lee, Li, Ciolino, Karmali, Sato.
                Acquisition, analysis, or interpretation of data: Persell, Peprah, Lipiszko, Lee, Ciolino, Karmali, Sato.
                Drafting of the manuscript: Persell, Lipiszko.
                Critical revision of the manuscript for important intellectual content: All authors.
                Statistical analysis: Lipiszko, Lee, Ciolino.
                Obtained funding: Persell, Sato.
                Administrative, technical, or material support: Persell, Peprah, Lipiszko, Li, Karmali, Sato.
                Supervision: Persell, Peprah.
                Conflict of Interest Disclosures: Dr Persell reported previously receiving research funding from Pfizer and reported receiving grants from Omron Healthcare Co Ltd during the conduct of the study. Dr Li reported receiving salary and reimbursement for travel from Omron Healthcare Co Ltd. Dr Sato reported receiving salary and reimbursement for travel from Omron Healthcare Co Ltd. No other disclosures were reported.
                Funding/Support: This work was funded by Omron Healthcare Co Ltd paid to Northwestern University. Analyses were conducted by Northwestern University employees. Employees from Lark Technologies, Inc and Omron Healthcare Co Ltd participated in discussing the results and revising the manuscript. Northwestern University investigators retained the right to publish and what content to publish independent of the funder.
                Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Additional Contributions: Kevin DeLury, MBA (Lark Technologies, Inc), provided valuable input coordinating the study activities with Lark Technologies, Inc and describing the application’s functionality. Mr DeLury is employed by Lark Technologies, Inc and did not receive other specific compensation for assisting with this study. Tammy A. Kennedy, BS, MT (Omron Healthcare Co Ltd), provided support in coordinating study activities with Omron. Ms Kennedy did not receive other specific compensation for assisting with the study.
                Data Sharing Statement: See Supplement 3.
                Article
                zoi200023
                10.1001/jamanetworkopen.2020.0255
                7052730
                32119093
                86cbb324-64e6-48d8-b872-c536fc6e168b
                Copyright 2020 Persell SD et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY-NC-ND License.

                History
                : 13 August 2019
                : 17 December 2019
                Categories
                Research
                Original Investigation
                Online Only
                Cardiology

                Comments

                Comment on this article